News Daily News Addition of Biomarkers May Fine Tune Risk Stratification in Atrial Fibrillation Michael O'Riordan October 07, 2016
News Conference News ESC 2016 NOACs as Effective as Warfarin for Reducing Stroke, but Apixaban and Dabigatran May Carry Lower Bleeding Risk: Registry Michael O'Riordan August 28, 2016
News Conference News ESC 2016 ICDs Do Not Reduce Mortality in Patients With HF Not Caused by Coronary Artery Disease: DANISH Michael O'Riordan August 28, 2016
News Daily News Increased Risk of In-Hospital Complications, Including Mortality, Among A-fib Patients Undergoing PCI Michael O'Riordan August 24, 2016
News Daily News FDA Declines to Approve Portola’s Reversal Agent for Factor Xa Inhibitors Michael O'Riordan August 18, 2016
News Daily News New A-fib Performance and Quality Measures Emphasize Shared Decision-Making, Inpatient and Outpatient Care Michael O'Riordan June 29, 2016
News Daily News Black Individuals Have Less A-fib, but When They Do, the Consequences Are More Dire Michael O'Riordan June 24, 2016
News Daily News Serious Cardiac Events, Including Death, Linked to Abuse of Antidiarrheal Medication Loperamide Michael O'Riordan June 08, 2016
News Daily News Los Episodios Cardíacos Serios, incluida la Muerte se asocian a un Abuso del Fármaco Antidiarréico Lorepamida Michael O'Riordan June 08, 2016
News Daily News Publica la AHA declaración sobre los desfibriladores portátiles y advierte que los datos sobre su eficacia son limitados Michael O'Riordan March 31, 2016
News Daily News AHA Issues Statement on Wearable Defibrillators, Cautions That Effectiveness Data Are Limited Michael O'Riordan March 31, 2016